Leica Biosystems

Anti-bcl-2 Oncoprotein Monoclonal Antibody, Unconjugated

#NCL-bcl-2-486 · western blot

6
Citing papers
50
Combined citations
Supplier page Find this product

Research areas

Cell death mechanisms and regulation2Cancer-related Molecular Pathways1Cardiac and Coronary Surgery Techniques1Cardiovascular Conditions and Treatments1Coronary Interventions and Diagnostics1Ear and Head Tumors1Genital Health and Disease1Heart rate and cardiovascular health1

Papers citing this product

1
Caspase-3 and Bcl-2 expression in glioblastoma: an immunohistochemical study
Arquivos de Neuro-Psiquiatria·2010·38 cit.·DOI
2
Expression of apoptosis in human saphenous vein grafts in restoration of blood flow through coronary bypass surgery
Brazilian Journal of Cardiovascular Surgery·2009·6 cit.·DOI
3
c-kit and bcl-2 Are Not Useful Markers in Differentiating Adenoid Cystic Carcinoma from Polymorphous Low-Grade Adenocarcinoma
ISRN Pathology·2011·3 cit.·DOI
4
Immunohistochemistry Analysis of Proteins Related with Apoptosis as Prognostic Factor inEpidermoid Carcinomaof Penis
International Journal of Morphology·2012·3 cit.·DOI
5
Ivabradine Preserves Cardiac Structure and Reduces Cell Death in Four Dogs With Preclinical Mitral Valve Disease
Veterinary Medicine and Science·2026·DOI
6
Pathological alteration and caspase-dependent activity of feline kidneys in natural infection of feline morbillivirus
BMC Veterinary Research·2025·DOI

Also available from other vendors

This target has 177 citing papers across all vendors combined

VendorProductPricePapers
Leica BiosystemsAnti-bcl-2 Oncoprotein Monoclonal Antibody, Unconjugated—1
Leica BiosystemsAnti-bcl-2 Oncoprotein Monoclonal Antibody, Unconjugated—16
Leica BiosystemsAnti-bcl-2 Oncoprotein Monoclonal Antibody, Unconjugated—2
DSHBBCL2-like 2 antibody - Clinical Proteomics Technologies for Cancer; National Cancer Institute—157
DSHBBCL2-like 2 antibody - Clinical Proteomics Technologies for Cancer; National Cancer Institute—157
DSHBBCL2 like 1 antibody - Clinical Proteomics Technologies for Cancer; National Cancer Institute—1
DSHBBCL2 like 1 antibody - Clinical Proteomics Technologies for Cancer; National Cancer Institute—157
DSHBBCL2 like 1 antibody - Clinical Proteomics Technologies for Cancer; National Cancer Institute—157
DSHBBCL2-like 2 antibody - Clinical Proteomics Technologies for Cancer; National Cancer Institute—157

Similar products

ProductVendorPricePapers
Anti-bcl-2 Oncoprotein Monoclonal Antibody, UnconjugatedLeica Biosystems—16
Anti-bcl-2 Oncoprotein Monoclonal Antibody, UnconjugatedLeica Biosystems—2
Anti-bcl-2 Oncoprotein Monoclonal Antibody, UnconjugatedLeica Biosystems—1
Anti-bcl-2 Oncoprotein Monoclonal Antibody, Unconjugated — Evidence — PubIndex